Byrna Technologies Inc. has announced the appointment of Matthew McBrady, Ph.D., to its Board of Directors. The appointment, which is effective immediately, increases the size of the Board from seven to eight members. The filing indicates that Dr. McBrady was appointed to fill a vacancy created by the expansion of the Board.
Dr. McBrady, aged 55, currently serves as the Chief Financial Officer of GoBrands, Inc., the parent company of GoPuff, a global quick commerce company, a position he has held since 2025. Prior to his tenure at GoBrands, he spent five years as a Professor of Practice in Finance at the Darden Graduate School of Business Administration at the University of Virginia. His career also includes over a decade in private equity and hedge fund investing, including roles as Managing Director and Chief Investment Officer of the Multi-Strategy Hedge Funds at BlackRock, Inc., Managing Director and Head of Investment Strategy and Risk Management at Silver Creek Capital Management, and Senior Associate and Vice President in the North American Private Equity group at Bain Capital.
Before his current roles, Dr. McBrady held academic positions at the Wharton School of the University of Pennsylvania and the Darden School. He also served as an international economist for President Clinton’s Council of Economic Advisers and the U.S. Department of the Treasury from 1998 to 2000. Additionally, he is currently an advisor to several impact investing funds and serves as a Director and Chair of Global Partnerships, a non-profit impact investor. He previously served on the board of Axon Enterprise (Nasdaq: AXON) from 2001 to 2014 and again from 2016 to 2026, during which he chaired the Audit Committee, Compensation Committee, and the M&A and Capital Structure Committee.
The Company stated that Dr. McBrady will receive compensation consistent with its standard non-employee director program. The filing notes that there are no family relationships between Dr. McBrady and any director or executive officer of the Company and no arrangements or understandings regarding his appointment other than those described in the Company’s standard proxy statement.
